Association and epidemiologic features of Trypanosoma cruzi and human T cell lymphotropic a virus type II in inhabitants of the Paraguayan Gran Chaco

American Journal of Tropical Medicine and Hygiene

Volumn 68, Issue 2, 2003, Pages 235-241

  Ferrer, Jorge F ^a   Esteban, Eduardo ^b   Murua, Alicia ^b   Gutierrez, Silvina ^b   Dube, Syamalima ^c   Poiesz, Bernard ^c   Feldman, Leonardo ^b   Basombrio, Miguel A ^d   Galligan, David ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSIDAD NACIONAL DEL CENTRO DE LA PROVINCIA DE BUENOS AIRES   (Argentina)

^c SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^d UNIVERSIDAD NACIONAL DE SALTA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; AMERICAN INDIAN; ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; ETHNIC DIFFERENCE; FAMILY; FEMALE; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 2; INFECTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PARAGUAY; PREVALENCE; RACE DIFFERENCE; RISK FACTOR; SCHOOL CHILD; SERODIAGNOSIS; SEROPREVALENCE; SEX DIFFERENCE; SEX RATIO; TRYPANOSOMA CRUZI; VIRUS INFECTION; ANIMAL; CHAGAS DISEASE; CHILD; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNOLOGY; ISOLATION AND PURIFICATION; MIDDLE AGED; PRESCHOOL CHILD; SOCIOECONOMICS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 2; PROTOZOA; RNA VIRUSES; TRYPANOSOMA; TRYPANOSOMA CRUZI;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANIMALS; CHAGAS DISEASE; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HTLV-II INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; INDIANS, SOUTH AMERICAN; MALE; MIDDLE AGED; PARAGUAY; PREVALENCE; RISK FACTORS; SEX FACTORS; SOCIOECONOMIC FACTORS; TRYPANOSOMA CRUZI;

EID: 0037313562     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2003.68.235     Document Type: Article

References (17)

1. World Health Organization Expert Committee, 1991. Control of Chagas Disease. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 811: 1-95.
2. Storino R, Barragan H, 1994. Epidemiologia. Storino R, Milei J, eds. Enfermedad de Chagas. Madrid: Mosby-Doyma Press, 51-74.
3. Gorla DE, Schofield CJ, 1989. Population dynamics of Triatoma infestans under natural climatic conditions in the Argentine Chaco. Med Vet Entomol 3: 179-194.
4. Kirchhoff L, Gam A, Gilliam F, 1987. American trypanosomiasis (Chagas' disease) in Central American immigrants. Am J Med 82: 915-920.
5. Schmuñis GA, 1991. Trypanosoma cruzi, the etiological agent of Chagas' disease: status in the blood supply in endemic and non-endemic countries. Transfusion 31: 547-557.
6. Mott KE, Miniz TM, Lehman JS Jr, Hoff R, Morrow RH, Oliveira TS, Sherlock IA, Draper CC, 1978. House construction, triatomine distribution and household distribution of seroreactivity to Trypanosoma cruzi in a rural community in northeast Brazil. Am J Trop Med Hyg 27: 1116-1122.
7. Gürtler RE, Chuit R, Cécere MC, Castañera MB, Cohen JE, Segura EL, 1998. Household prevalence of seropositivity for Trypanosoma cruzi in three rural villages in northwest Argentina: environmental, demographic, and entomologic associations. Am J Trop Med Hyg 59: 741-749.
8. Gürtler RE, Cohen JE, Cécere MC, Lauricella MA, Chuit R, Segura EL, 1998. Influence of humans and domestic animals in the household prevalence of Trypanosoma cruzi in Triatoma infestans populations in northwest Argentina. Am J Trop Med Hyg 58: 748-758.
9. Basombrio MA, Segovia A, Peralta-Ramos M, Esteban E, Stumpf R, Jurgensen RP, Winkler MA, Sayre K, Ferrer JF, 1999. Endemic Trypanozoma cruzi infection in Indian populations of the Gran Chaco territory of South America. Ann Trop Med Parasitol 93: 41-48.
10. Ferrer JF, Esteban E, Dube S, Basombrio MA, Segovia A, Peralta-Ramos M, Dube D K, Sayre K, Aguayo N, Hengst J, Poiesz BJ, 1996. Endemic infection with the human T lymphotropic virus type IIB in Argentinean and Paraguayan Indians: epidemiology and molecular characterization. J Infect Dis 174: 944-953.
11. Ferrer JF, Jonsson CB, Esteban E, Galligan D, Basombrio MA, Peralta-Ramos M, Bharadwaj M, Torrez-Martinez N, Callahan J, Segovia A, Hjelle B, 1998. High prevalence of hantavirus infection in Indian communities of the Paraguayan and Argentinean Gran Chaco. Am J Trop Med Hyg 58: 438-444.
12. Kierszenbaum F, Sztein MB, 1994. Chagas' disease (American trypanosomiasis). Kierszenbaum F, ed. Parasitic Infections and the Immune System. San Diego, CA: Academic Press, 53-85.
13. Murphy EL, Glynn SA, Fridey J, Smith JW, Sacher RA, Nass CC, Ownby HE, Wright DJ, Nemo GJ, 1999. Increased incidence of infectious disease during prospective follow-up of human lymphotropic virus type-II-and I-infected blood donors. Arch Intern Med 159: 1485-1491.
14. Murphy EL, Glynn SA, Fridey J, Sacher RA, Smith JW, Wright DJ, Newman B, Gibble JW, Ameti DI, Nass CC, Schreiber GB, Nemo GJ, 1997. Increased prevalence of infectious diseases and other adverse outcomes in human T lymphotropic virus type I-and II-infected blood donors. J Infect Dis 176: 1468-1475.
15. Modahl LE, Young KC, Varney KF, Khayam-Bashi H, Murphy EL, 1997. Injection drug users seropositive for HTLV-II are at increased risk for pneumonia, abscess and lymphoadenopathy. J Acquir Immune Defic Syndr Hum Retrovirol 16: 169-175.
16. Gonzalez LM, Lindsey AE, Hjelle B, Dominguez D, Brown J, Jonsson CB, 2001. Prevalence of antibodies to Sin Nombre virus in humans living in rural areas of southern New Mexico and western Texas. Virus Res 74: 177-179.
17. Allison P, 1999. Logistic Regression Using the SAS System: Theory and Application. Cary NC: SAS Institute, Inc., 31-78.